Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines

Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia's AI-based capabilities and personalised medicine platform from target identification

Related Keywords

Miami ,Florida ,United States ,Boston ,Massachusetts ,Osaka ,Japan ,Vienna ,Wien ,Austria ,Eva Schaefer Jansen ,Frank Nestle ,Amanda Galgay ,Arnaud Delepine ,Felix Lauscher ,Andrew Hopkins ,Nathalie Pham ,Sandrine Guendoul ,Sara Sherman ,Sally Bain ,Global Head Of Research ,Twitter ,Global Head ,Chief Scientific Officer ,Private Securities Litigation Reform Act ,Statement Regarding Forward Looking ,Exscientia ,Sanofi ,Stablish ,Strategic ,Research ,Collaboration ,Evelop ,Riven ,Pipeline ,Precision ,Engineered ,Medicines ,